$0
Director
2017
Director at Scleroderma Clinical Trials Consortium Inc.
Fiscal year ended December 31, 2017. Published on January 24, 2026.
Total compensation
Robert Lafyatis, M.D. has been listed as an employee of Scleroderma Clinical Trials Consortium Inc. in Form 990 filings since fiscal year 2017.